View Press Release
View PowerPoint Presentation
Theodore Hong, MD
To evaluate liver-directed radiation therapy with respect to overall survival (OS) for patients with unresectable, localized intrahepatic cholangiocarcinoma.
Pathologically (histologically or cytologically) proven diagnosis of IHC without distant extrahepatic metastasis
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website